0001415889-24-014370.txt : 20240523 0001415889-24-014370.hdr.sgml : 20240523 20240523180245 ACCESSION NUMBER: 0001415889-24-014370 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240522 FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pruzanski Mark CENTRAL INDEX KEY: 0001559569 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38692 FILM NUMBER: 24980070 MAIL ADDRESS: STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC. STREET 2: 18 DESBROSSES ST. CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Equillium, Inc. CENTRAL INDEX KEY: 0001746466 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821554746 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 105 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 412-5302 MAIL ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 105 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 form4-05232024_100533.xml X0508 4 2024-05-22 0001746466 Equillium, Inc. EQ 0001559569 Pruzanski Mark 2223 AVENIDA DE LA PLAYA, SUITE 105 LA JOLLA CA 92037 true false false false 0 Stock Option (right to buy) 1.43 2024-05-22 4 A 0 20000 0 A 2034-05-22 Common Stock 20000 20000 D The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date. /s/ Jason A. Keyes, Attorney-in-Fact for Mark Pruzanski, M.D. 2024-05-23